一种用于预测年轻和中年患者接受维持血液透析的死亡风险的新型血红图:一项回顾性研究
Lei Sun1,2, Yue Zhang1,2, Xinliang Zuo1,2
1Chaohu Clinical Medical College of Anhui Medical University, Hefei, China.
Frontiers in medicine
|January 22, 2025
概括
一个新的诺莫图谱预测了年轻和中年维持血液透析 (MHD) 患者的死亡风险. 关键因素包括年龄,血红蛋白,血清,NLR和PAR,为改善临床决策提供了帮助.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 临床流行病学 临床流行病学
背景情况:
- 维持血液透析 (MHD) 患者人数正在增长,年轻人比例越来越高.
- 年轻的MHD患者面临显著的死亡风险,但缺乏专门的预测工具.
- 现有的研究往往忽视了这一人口群体中独特的挑战和风险因素.
研究的目的:
- 确定年轻和中年MHD患者死亡率的关键决定因素.
- 开发和验证这个特定群体中死亡风险的预测模型.
- 加强临床决策和患者管理策略.
主要方法:
- 从2019年1月到2024年1月,研究了一组127名年轻和中年MHD患者的队列.
- 后勤回归确定了死亡率的独立预测因素:年龄,血红蛋白 (HB),血清 (Mg),中性粒细胞与淋巴细胞的比率 (NLR) 和血小板与白蛋白的比率 (PAR).
- 使用AUC-ROC,校准曲线,Hosmer-Lemeshow测试和决策曲线分析 (DCA) 构建和验证了一个名图.
主要成果:
- 该研究发现,该队列的死亡率为22.83%.
- 年龄,HB,血清Mg,NLR和PAR是死亡率的重要独立预测因素.
- 开发的名图表显示出高分辨能力 (AUC=0.899) 和优异的校准,DCA显示出显著的临床实用性.
结论:
- 一个经过验证的纳米图,包括年龄,HB,血清Mg,NLR和PAR,可以准确预测年轻和中年MHD患者的死亡风险.
- 这种模型提供了高度的区分和校准,证明了临床上与风险分层相关.
- 这些发现支持为这个不断增长的患者小组量身定制的风险评估工具的需求.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
205
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
2.1K
相关概念视频
Dialysis
256
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
256
Renal Failure: Dose Adjustments
61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
Factors Affecting Renal Clearance: Renal Impairment
50
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
50
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
70
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
70
Kaplan-Meier Approach
83
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
83
